OTC Rhinitis Relief
Scouting breakthrough concepts for a leading consumer-health company to deliver rapid onset, long-lasting efficacy, and sustainable design for allergic rhinitis sufferers.
Client
Leading Consumer-Health Company
Objective
Shortlist Novel OTC Concepts
Timeline
10-Week Program
Key Focus
Rapid Onset & Sustainability
The Challenge: Re-inventing a Crowded Market
Current over-the-counter (OTC) options for allergic rhinitis can be slow, sedating, or awkward to use, leading to poor user adherence. The opportunity existed to design a superior consumer therapy by focusing on four key innovation areas.
Active & Excipient Innovation
Delivery Hardware
Digital Adherence
Sustainability
Key Outcomes: Three Lead Concepts for a 2026 Launch
Our 6-phase program, including SME interviews and prototype formulation, delivered three viable, consumer-validated concepts ready for full development.
1. Nano Oral-Film Bilastine
A fast-dissolving oral film for ultimate convenience and discretion.
~10 min
ONSET
16 hr
RELIEF
2. Propellant-Free Nasal Micro-Mist
An azelastine powder delivered via a soft-mist device in a 100% recyclable canister.
~8 min
ONSET
12 hr
RELIEF
3. Synbiotic Chew Tablet
A combination of lactobacillus and quercetin positioned for long-term immune modulation.
Daily
USE
Long-Term
BENEFIT
Strategic Impact
Armed with SME-validated prototypes and clear sustainability data, the client approved full development of the nasal micro-mist and oral-film products. A launch is slated for Q4 2026, positioning the brand as the first fast-acting, environmentally responsible allergic-rhinitis relief on mass-market shelves.